Genomics and Evolutionary Medicine Unit (GEM), Center of Excellence in Malaria Research, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
PLoS Pathog. 2018 Apr 26;14(4):e1006923. doi: 10.1371/journal.ppat.1006923. eCollection 2018 Apr.
It is rare to come across an Aesop's fable in respectable journals. It might catch scientists outside the malaria field by surprise to learn that the famous story of "The Boy Who Cried Wolf" has been repeatedly compared to the threat from artemisinin-resistant malaria parasites, including the two latest reports on the rise of a specific haplotype in Cambodia and Thailand, sensationally dubbed "Super Malaria" by the media [1, 2]. The comparison to a children's tale should not negate the fact that malaria drug resistance is one of the most pressing threats to the global public health community. Here, the findings leading to this contentious discourse will be delineated in order to provide a perspective. Possible solutions will be presented to stimulate further research and discussion to solve one of the greatest public health challenges of our lifetime.
在有声望的期刊上很少能看到伊索寓言。如果让疟疾领域以外的科学家们了解到,著名的“狼来了”的故事被反复比作来自青蒿素耐药疟原虫的威胁,包括最近关于柬埔寨和泰国特定单倍型上升的两份报告,被媒体耸人听闻地称为“超级疟疾”[1,2],他们可能会感到惊讶。将这种情况比作一个儿童故事,不应否定这样一个事实,即疟疾耐药性是对全球公共卫生界的最紧迫威胁之一。在这里,将阐述导致这一有争议的讨论的发现,以便提供一个视角。将提出可能的解决方案,以激发进一步的研究和讨论,以解决我们一生中最大的公共卫生挑战之一。